Sodium hydride → 4-(3,3-Dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline

HRID 1618483Notes

Reaction equation

[CH3:1][C:2]1([CH3:17])[C:10]2[C:5](=[CH:6][C:7]([N:11]3[CH2:16][CH2:15][O:14][CH2:13][CH2:12]3)=[CH:8][CH:9]=2)[NH:4][CH2:3]1.Cl[C:19]1[C:28]2[C:23](=[CH:24][C:25]([F:29])=[CH:26][CH:27]=2)[N:22]=[C:21]([C:30]2[CH:35]=[CH:34][CH:33]=[CH:32][N:31]=2)[C:20]=1[CH3:36].[H-].[Na+]>CN(C=O)C>[CH3:1][C:2]1([CH3:17])[C:10]2[C:5](=[CH:6][C:7]([N:11]3[CH2:16][CH2:15][O:14][CH2:13][CH2:12]3)=[CH:8][CH:9]=2)[N:4]([C:19]2[C:28]3[C:23](=[CH:24][C:25]([F:29])=[CH:26][CH:27]=3)[N:22]=[C:21]([C:30]3[CH:35]=[CH:34][CH:33]=[CH:32][N:31]=3)[C:20]=2[CH3:36])[CH2:3]1

Participants

Conditions

Temperature: 130 °C

Procedure

Prepared according to procedure M using 3,3-dimethyl-6-morpholinoindoline (85 mg, 0.367 mmol) in DMF (6 mL), 4-chloro-7-fluoro-3-methyl-2-(pyridin-2-yl)quinoline (100 mg, 367 μmol) and sodium hydride (18 mg, 733 μmol) and heating at 130° C. overnight. After purification 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline was obtained as a yellow film. 1H NMR (500 MHz, chloroform-d) δ ppm 8.73-8.76 (1H, m), 7.80-7.94 (4H, m), 7.40 (1H, ddd, J=7.6, 4.9, 1.5 Hz), 7.20-7.27 (1H, m), 7.08 (1H, d, J=8.3 Hz), 6.31 (1H, dd, J=8.1, 2.2 Hz), 5.59 (1H, d, J=2.4 Hz), 3.69-3.81 (6H, m), 2.89-3.03 (4H, m), 2.37 (3H, s), 1.51 (3H, s), 1.46 (3H, s). Mass Spectrum (ESI) m/e=469 (M+1).

Workup

customPrepared
customAfter purification 4-(3,3-dimethyl-6-(4-morpholinyl)-2,3-dihydro-1H-indol-1-yl)-7-fluoro-3-methyl-2-(2-pyridinyl)quinoline
customwas obtained as a yellow film

Sources & evidence

ORD record: ord-900b549539b342cf9356f28bbd8c009e
Source dataset: uspto-grants-2014_07
DOI: 10.6084/m9.figshare.5104873.v1
Patent number: US08765940B2

Reaction notes

Loading…